Formed as a special purpose acquisition company, the firm was created to identify and merge with businesses in the life sciences and biotechnology sectors. Backed by healthcare-focused investors, it raised capital in public markets to pursue acquisitions involving drug development, diagnostics, or r...
1 member of Congress has disclosed 5 trades in CM Life Sciences, Inc. (CMLFU), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-03-08 | Tom Malinowski | buy | $1K – $15K |
| 2021-03-05 | Tom Malinowski | buy | $1K – $15K |
| 2021-02-25 | Tom Malinowski | buy | $15K – $50K |
| 2020-10-16 | Tom Malinowski | buy | $1K – $15K |
| 2020-10-15 | Tom Malinowski | buy | $1K – $15K |